Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen's 13F stock portfolio on a quarterly basis. It is based on Viking Global's regulatory 13F Form filed on 08/14/2019. Please visit our Tracking Ole Andreas Halvorsen's Viking Global...
The Trump administration has allocated $1.8B to help states and local governments tackle opioid addiction in their respective areas. The funds will be distributed through Substance Abuse and Mental Health Services and the CDC for treatment and data gathering. More news on: Teva Pharmaceu...
Results for Glatiramer Acetate (GA) Depot 3 year analysis in RRMS, GA Depot safety results in RRMS and PPMS, and novel anti-BMP for remyelination will be presented ECTRIMS 2019 to be held in Helsinki, Sweden on September 11-13 NESS ZIONA, Israel, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Mapi...
On August 28th, Adamis Pharmaceuticals ( ADMP ) updated investors on the U.S. launch of its SYMJEPI (0.3 mg) and SYMJEPI Jr. (0.15 mg) epinephrine injections. If you haven’t been following Adamis and the SYMJEPI saga, you should know that SYMJEPI 0.3 mg received FDA approval back in J...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 08/14/2019. Please visit our Tracking John Paulson's Paulson & Company Portfolio serie...
The easy buy and sell pattern on shares of Bausch Health Companies ( BHC ) came to an end after its last quarterly earnings report. In the past few quarters, investors enjoyed gains by buying BHC stock ahead of the earnings report and then selling it after the company beat expectations. This...
An Oklahoma district court has ordered Johnson & Johnson (NYSE: JNJ ) to pay $572M over its role in the opioid epidemic there. One-time co-defendants Purdue Pharma and Teva Pharmaceutical Industries (NYSE: TEVA ) settled earlier for $270M and $85M, respectively. More news on: John...
Quick Take TFF Pharmaceuticals ( TFFP ) has filed to raise gross proceeds of $22 million from a U.S. IPO, according to an S-1 registration statement . The firm is focused on developing and commercializing treatments for lung-related conditions. TFFP is proposing a fairly low valuation a...
On Friday, I published " Best Performing S&P 500 Stocks During Crisis ". As some market participants increasingly price recessionary scenarios into stock and bond prices, I thought it would be prudent to examine what worked during the last downturn. Reader, Edoardo F , commented that it w...
Novo Nordisk (NYSE: NVO ) has filed litigation in a Delaware district court against Mylan N.V. (NASDAQ: MYL ) aimed at blocking its attempt to market a generic version of top seller Victoza (liraglutide). The seven patents being challenged expire in 2021 - 2033. More news on: Novo Nordisk ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...